Cargando…
FRI505 A Rare Case Of Methimazole Induced Grave Agranulocytosis
Disclosure: N. Barua: None. S. Idriss: None. R. Panta: None. I. Jamal: None. J. Hodge: None. Introduction: Agranulocytosis is a rare side effect of methimazole that usually occurs in a dose-dependent fashion within the first 3 to 6 months of initiation. It occurs in 0.2 - 0.5% of patients with Grave...
Autores principales: | Barua, Nabonita, Idriss, Setana, Panta, Raju, Jamal, Issra, Hodge, Jordesha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555748/ http://dx.doi.org/10.1210/jendso/bvad114.1851 |
Ejemplares similares
-
SAT249 Femur Lysis Calcium Crisis
por: Gupta, Gunjan, et al.
Publicado: (2023) -
FRI234 A Pregnancy With Two Special Surprises A Baby And A Nonhemorrhagic Adrenal Infarction During Pregnancy
por: Idriss, Setana, et al.
Publicado: (2023) -
SAT-600 Relapse of Agranulocytosis after Recovery of Methimazole-Induced Agranulocytosis
por: Choi, Dughyun, et al.
Publicado: (2019) -
SAT-625 Dose-Dependent, Methimazole-Induced Agranulocytosis in a Pregnant Hispanic Woman with Grave's Disease
por: Bello, Fatimah, et al.
Publicado: (2019) -
PSAT344 Zeroing In: Methimazole Induced Agranulocytosis in Amiodarone Induced Thyrotoxicosis
por: Gunda, Mouna, et al.
Publicado: (2022)